DORTMUND, GERMANY -- (MARKET WIRE) -- September 08, 2006 -- The Dortmund, Germany-based biotech company Protagen AG expands its board of directors from three to five members. In the last general meeting it was decided to enlarge the Board of Directors by two representatives of the investors of the last financing round. Professor Kleemann was reelected as Chairman of the Board of Directors.
